The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Vaxcyte Inc (NASDAQ: PCVX) closed at $47.7 up 6.71% from its previous closing price of $44.7. In other words, the price has increased by $6.71 from its previous closing price. On the day, 1.93 million shares were traded. PCVX stock price reached its highest trading level at $48.11 during the session, while it also had its lowest trading level at $44.46.
Ratios:
For a deeper understanding of Vaxcyte Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.83 and its Current Ratio is at 8.83. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on September 12, 2025, initiated with a Neutral rating and assigned the stock a target price of $38.
On December 20, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $135.Goldman initiated its Buy rating on December 20, 2024, with a $135 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 05 ’25 when Eydelman Mikhail sold 5,000 shares for $70.74 per share. The transaction valued at 353,699 led to the insider holds 41,620 shares of the business.
Eydelman Mikhail bought 5,000 shares of PCVX for $344,350 on Mar 05 ’25. On Mar 03 ’25, another insider, Wassil Jim, who serves as the CHIEF OPERATING OFFICER of the company, sold 8,000 shares for $73.27 each. As a result, the insider received 586,165 and left with 154,931 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 6244229120 and an Enterprise Value of 4617351680.
Stock Price History:
The Beta on a monthly basis for PCVX is 1.35, which has changed by -0.503554 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, PCVX has reached a high of $94.60, while it has fallen to a 52-week low of $27.66. The 50-Day Moving Average of the stock is 10.10%, while the 200-Day Moving Average is calculated to be 15.34%.
Shares Statistics:
For the past three months, PCVX has traded an average of 1.72M shares per day and 1609090 over the past ten days. A total of 130.03M shares are outstanding, with a floating share count of 126.92M. Insiders hold about 3.05% of the company’s shares, while institutions hold 107.24% stake in the company. Shares short for PCVX as of 1763078400 were 9336796 with a Short Ratio of 5.42, compared to 1760486400 on 10013969. Therefore, it implies a Short% of Shares Outstanding of 9336796 and a Short% of Float of 7.9799999999999995.
Earnings Estimates
The market rating of Vaxcyte Inc (PCVX) is currently shaped by the ongoing analysis conducted by 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$1.53, with high estimates of -$1.18 and low estimates of -$1.89.
Analysts are recommending an EPS of between -$4.19 and -$6.44 for the fiscal current year, implying an average EPS of -$5.31. EPS for the following year is -$6.22, with 6.0 analysts recommending between -$4.16 and -$7.9.
